(DECT) AIM Products Trust - - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US00888H8363 • Defined Outcome
DECT: Equity, Options, Contracts, Expiration, Customized, Outcomes, Investing
The Advisor for the AllianzIM U.S. Large Cap Buffer10 Dec ETF (NYSE ARCA: DECT) primarily invests in FLEX Options that reference the performance of an underlying ETF. These FLEX Options are exchange-traded, customizable contracts that allow for tailored terms such as strike prices, styles, and expiration dates. The fund is classified as non-diversified, meaning it can concentrate its investments in fewer securities, which may increase risk.
Ticker Symbol: DECT | Exchange: NYSE ARCA | Type: ETF | Country Origin: USA | ETF Category: Defined Outcome
With an AUM of $113.92 million, DECT demonstrates moderate scale in the defined outcome ETF category. Its average 20-day volume of 29,764 shares indicates limited trading activity, which may impact liquidity. The last price of $31.62 reflects current market valuation, while the SMA 20, 50, and 200 of $32.45, $32.31, and $31.72, respectively, suggest a narrowing range in recent prices. The ATR of 0.26 indicates low volatility, with price movements remaining relatively stable.
3-Month Forecast: Based on the convergence of SMA 20, SMA 50, and SMA 200 near $32.30, DECT is likely to trade within a range of $31.50 to $33.00 in the next quarter. Support is expected at $31.72 (SMA 200), while resistance may emerge at $32.45 (SMA 20). The low ATR of 0.26 suggests volatility will remain muted, with potential for gradual upside if market conditions stabilize. The funds AUM of $113.92 million provides sufficient liquidity to maintain its defined outcome strategy without significant premium/discount pressures.
Additional Sources for DECT ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DECT ETF Overview
Market Cap in USD | 114m |
Category | Defined Outcome |
TER | 0.74% |
IPO / Inception | 2022-11-30 |
DECT ETF Ratings
Growth 5y | 56.5% |
Fundamental | - |
Dividend | 5.50% |
Rel. Strength Industry | -5.63 |
Analysts | - |
Fair Price Momentum | 29.43 USD |
Fair Price DCF | - |
DECT Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 100.0% |
DECT Growth Ratios
Growth Correlation 3m | -13.7% |
Growth Correlation 12m | 87% |
Growth Correlation 5y | 97.3% |
CAGR 5y | 10.18% |
CAGR/Max DD 5y | 1.14 |
Sharpe Ratio 12m | 0.81 |
Alpha | -2.50 |
Beta | 0.42 |
Volatility | 16.89% |
Current Volume | 10.5k |
Average Volume 20d | 14.1k |
As of March 15, 2025, the stock is trading at USD 31.12 with a total of 10,472 shares traded.
Over the past week, the price has changed by -1.51%, over one month by -5.11%, over three months by -4.24% and over the past year by +4.46%.
Partly, yes. Based on ValueRay Analyses, AIM Products Trust - (NYSE ARCA:DECT) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 56.49 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DECT as of March 2025 is 29.43. This means that DECT is currently overvalued and has a potential downside of -5.43%.
AIM Products Trust - has no consensus analysts rating.
According to ValueRays Forecast Model, DECT AIM Products Trust - will be worth about 32.4 in March 2026. The stock is currently trading at 31.12. This means that the stock has a potential upside of +4.18%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 32.4 | 4.2% |